BACKGROUND: The massive use of antibiotics has led to the selection of resistant bacterial strains that are difficult to eradicate. Among these, Pseudomonas aeruginosa most frequently colonizes and infects the airways of cystic fibrosis patients. Cationic Antimicrobial Peptides (AMPs) represent interesting molecules for the development of new antimicrobial agents. Thanks to their mechanism of action that involves the permeabilization of the bacterial cytoplasmic membrane, the induction of resistance is quite limited. OBJECTIVE: The evaluation of the capability of two frog-skin derived AMPs, i.e. Esc(1-21) and its diastereomer Esc(1-21)-1c, to induce resistance in P. aeruginosa and synergize with aztreonam. METHOD: The induction of resistance was evaluated after 15 cycles of exposure to non-inhibitory growth concentrations of antibiotics and peptides. Subsequently, the Minimal Inhibitory Concentration (MIC) was calculated and compared to that obtained before drug exposure. Furthermore, MICs of AMPs and antibiotics were evaluated in Artificial Sputum Medium (ASM). Finally, the ability of the two peptides to synergize with aztreonam was determined by the checkerboard titration method. RESULTS: Pseudomonas aeruginosa acquired resistance to antibiotics, as evidenced by the increased MICs compared to the initial ones (from 8 to 128-fold higher), while no change in MICs was observed after multiple treatments with the Esc-peptides. In addition, both peptides showed significantly lower MICs than aztreonam in ASM. Finally, the diastereomer Esc(1-21)-1c had the ability to synergize with aztreonam in inhibiting growth and in killing Pseudomonas cells. CONCLUSION: Both peptides represent promising candidates for the development of new antipseudomonal compounds, which do not induce resistance.

Esculentin-1 aderived antipseudomonal peptides. limited induction of resistance and synergy with aztreonam / Casciaro, Bruno; Loffredo, Maria Rosa; Luca, Vincenzo; Verrusio, Walter; Cacciafesta, Mauro; Mangoni, Maria Luisa. - In: PROTEIN & PEPTIDE LETTERS. - ISSN 1875-5305. - 25:12(2018), pp. 1155-1162. [10.2174/0929866525666181101104649]

Esculentin-1 aderived antipseudomonal peptides. limited induction of resistance and synergy with aztreonam

Casciaro, Bruno;Loffredo, Maria Rosa;Luca, Vincenzo;Verrusio, Walter;Cacciafesta, Mauro;Mangoni, Maria Luisa
2018

Abstract

BACKGROUND: The massive use of antibiotics has led to the selection of resistant bacterial strains that are difficult to eradicate. Among these, Pseudomonas aeruginosa most frequently colonizes and infects the airways of cystic fibrosis patients. Cationic Antimicrobial Peptides (AMPs) represent interesting molecules for the development of new antimicrobial agents. Thanks to their mechanism of action that involves the permeabilization of the bacterial cytoplasmic membrane, the induction of resistance is quite limited. OBJECTIVE: The evaluation of the capability of two frog-skin derived AMPs, i.e. Esc(1-21) and its diastereomer Esc(1-21)-1c, to induce resistance in P. aeruginosa and synergize with aztreonam. METHOD: The induction of resistance was evaluated after 15 cycles of exposure to non-inhibitory growth concentrations of antibiotics and peptides. Subsequently, the Minimal Inhibitory Concentration (MIC) was calculated and compared to that obtained before drug exposure. Furthermore, MICs of AMPs and antibiotics were evaluated in Artificial Sputum Medium (ASM). Finally, the ability of the two peptides to synergize with aztreonam was determined by the checkerboard titration method. RESULTS: Pseudomonas aeruginosa acquired resistance to antibiotics, as evidenced by the increased MICs compared to the initial ones (from 8 to 128-fold higher), while no change in MICs was observed after multiple treatments with the Esc-peptides. In addition, both peptides showed significantly lower MICs than aztreonam in ASM. Finally, the diastereomer Esc(1-21)-1c had the ability to synergize with aztreonam in inhibiting growth and in killing Pseudomonas cells. CONCLUSION: Both peptides represent promising candidates for the development of new antipseudomonal compounds, which do not induce resistance.
antibiotic resistance; aztreonam; cystic fibrosis; esculentin-1a; pseudomonas aeruginosa; synergism.; amphibian proteins; antimicrobial cationic peptides; aztreonam; cystic fibrosis; drug resistance, bacterial; drug synergism; humans; microbial sensitivity tests; pseudomonas infections; pseudomonas aeruginosa; structural biology; biochemistry
01 Pubblicazione su rivista::01a Articolo in rivista
Esculentin-1 aderived antipseudomonal peptides. limited induction of resistance and synergy with aztreonam / Casciaro, Bruno; Loffredo, Maria Rosa; Luca, Vincenzo; Verrusio, Walter; Cacciafesta, Mauro; Mangoni, Maria Luisa. - In: PROTEIN & PEPTIDE LETTERS. - ISSN 1875-5305. - 25:12(2018), pp. 1155-1162. [10.2174/0929866525666181101104649]
File allegati a questo prodotto
File Dimensione Formato  
Casciaro_Esculentin-1a_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 693.99 kB
Formato Adobe PDF
693.99 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1244254
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 21
social impact